A detailed history of Tiemann Investment Advisors, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Tiemann Investment Advisors, LLC holds 11,200 shares of PFE stock, worth $289,968. This represents 0.14% of its overall portfolio holdings.

Number of Shares
11,200
Previous 11,850 5.49%
Holding current value
$289,968
Previous $331,000 2.11%
% of portfolio
0.14%
Previous 0.15%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$27.7 - $31.39 $18,005 - $20,403
-650 Reduced 5.49%
11,200 $324,000
Q2 2024

Aug 12, 2024

SELL
$25.26 - $29.6 $23,365 - $27,380
-925 Reduced 7.24%
11,850 $331,000
Q1 2024

May 13, 2024

SELL
$25.89 - $29.73 $14,239 - $16,351
-550 Reduced 4.13%
12,775 $354,000
Q4 2023

Feb 14, 2024

BUY
$26.13 - $33.94 $5,226 - $6,788
200 Added 1.52%
13,325 $383,000
Q3 2023

Nov 13, 2023

SELL
$32.09 - $37.51 $22,463 - $26,257
-700 Reduced 5.06%
13,125 $435,000
Q2 2023

Aug 11, 2023

SELL
$36.12 - $41.79 $27,992 - $32,387
-775 Reduced 5.31%
13,825 $507,000
Q1 2023

May 11, 2023

SELL
$39.39 - $51.28 $43,447 - $56,561
-1,103 Reduced 7.02%
14,600 $595,000
Q4 2022

Feb 14, 2023

BUY
$41.75 - $54.5 $43,712 - $57,061
1,047 Added 7.14%
15,703 $804,000
Q3 2022

Nov 15, 2022

BUY
$43.76 - $53.42 $8,752 - $10,684
200 Added 1.38%
14,656 $641,000
Q2 2022

Aug 12, 2022

SELL
$46.53 - $55.17 $4,653 - $5,517
-100 Reduced 0.69%
14,456 $758,000
Q1 2022

May 13, 2022

BUY
$45.75 - $56.69 $59,475 - $73,697
1,300 Added 9.81%
14,556 $754,000
Q4 2021

Feb 14, 2022

BUY
$41.32 - $61.25 $7,231 - $10,718
175 Added 1.34%
13,256 $783,000
Q3 2021

Nov 15, 2021

SELL
$39.25 - $50.42 $12,756 - $16,386
-325 Reduced 2.42%
13,081 $563,000
Q2 2021

Aug 13, 2021

BUY
$35.91 - $40.68 $2,693 - $3,051
75 Added 0.56%
13,406 $525,000
Q1 2021

May 12, 2021

BUY
$33.49 - $37.77 $381,350 - $430,086
11,387 Added 585.75%
13,331 $483,000
Q1 2021

May 11, 2021

SELL
$33.49 - $37.77 $393,072 - $443,306
-11,737 Reduced 85.79%
1,944 $1.04 Million
Q4 2020

Feb 16, 2021

BUY
$33.47 - $42.56 $45,184 - $57,456
1,350 Added 10.95%
13,681 $504,000
Q3 2020

Nov 12, 2020

SELL
$31.75 - $37.25 $4,762 - $5,587
-150 Reduced 1.2%
12,331 $453,000
Q2 2020

Aug 13, 2020

BUY
$30.12 - $36.54 $4,518 - $5,481
150 Added 1.22%
12,481 $408,000
Q1 2020

May 15, 2020

SELL
$27.03 - $38.62 $675 - $965
-25 Reduced 0.2%
12,331 $402,000
Q4 2019

Feb 13, 2020

SELL
$32.92 - $37.36 $31,241 - $35,454
-949 Reduced 7.13%
12,356 $484,000
Q3 2019

Nov 15, 2019

SELL
$32.49 - $42.13 $54,420 - $70,567
-1,675 Reduced 11.18%
13,305 $478,000
Q2 2019

Aug 13, 2019

BUY
$36.98 - $41.52 $11,167 - $12,539
302 Added 2.06%
14,980 $649,000
Q4 2018

Feb 14, 2019

SELL
$38.47 - $43.86 $81,748 - $93,202
-2,125 Reduced 12.65%
14,678 $641,000
Q3 2018

Nov 13, 2018

BUY
$34.47 - $41.81 $6,894 - $8,362
200 Added 1.2%
16,803 $741,000
Q1 2018

May 15, 2018

BUY
$31.91 - $37.02 $20,741 - $24,063
650 Added 4.07%
16,603 $589,000
Q4 2017

Feb 15, 2018

BUY
$33.26 - $35.29 $8,315 - $8,822
250 Added 1.59%
15,953 $578,000
Q3 2017

Nov 15, 2017

SELL
$31.0 - $34.15 $6,975 - $7,683
-225 Reduced 1.41%
15,703 $561,000
Q2 2017

Aug 14, 2017

BUY
N/A
15,928
15,928 $535,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $145B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Tiemann Investment Advisors, LLC Portfolio

Follow Tiemann Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tiemann Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tiemann Investment Advisors, LLC with notifications on news.